SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
Scribe Therapeutics, Inc.
@SCTX_InsiderForm 4 Filing: Parrot David Buys $39,990 of $SCTX
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Scribe Therapeutics, Inc.
Ticker: $SCTX
Transaction Value
$39,990
Price/Share: $15.00
transaction date
2026-07-23
Shares: 2,666
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Parrot David, holds the title of Chief Financial Officer at Scribe Therapeutics, Inc..
On 2026-07-23, the insider transacted 2,666 shares.The shares were transacted at a weighted average price of $15.00 per share, resulting in a total market-relevant value of $39,990.
Executive Summary Summary
Parrot David (Chief Financial Officer) bought $40K of $SCTX
Post-Transaction Position: 1,333 shares
SEC Accession No: 0002127908-26-000004 (CIK: 2127908)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.